Final Day to Apply for Anthem Biosciences IPO: Investor Interest, Market Buzz, and Key Numbers Explained
Anthem Biosciences—one of the prominent names in the contract research and manufacturing space—is seeing massive attention in the stock market with its IPO, and today is the last chance for investors to submit their bids.
In this detailed article, we’ll explain everything in simple and easy-to-follow points—from how well the IPO has been received by investors to the latest updates on the grey market premium (GMP). Whether you're a seasoned investor or a beginner just exploring IPOs, this guide will help you make an informed choice.
Who is Anthem Biosciences?
Before diving into the IPO performance, let’s understand what Anthem Biosciences actually does:
-
Pharmaceutical R&D Company:
-
Specializes in research, development, and manufacturing services for global pharma and biotech firms.
-
-
Strong Client Base Worldwide:
-
Works with large multinational clients in the healthcare, biotechnology, and chemical industries.
-
-
Cutting-Edge Infrastructure:
-
Operates from a world-class facility based in Bengaluru, offering integrated drug development services.
-
-
Profitability & Growth Track Record:
-
Shows consistent financial growth with a solid business model that supports global demand.
-
IPO Timeline: Today is the Final Day!
-
IPO Opened On: July 12, 2025
-
IPO Closes On: July 16, 2025 (Today)
-
Allotment Date: July 18, 2025
-
Listing Date (Expected): July 22, 2025
Reminder: You have time till 5 PM today to submit your IPO bid through your broker or trading platform.
IPO Details at a Glance
-
Price Band:
-
₹436 to ₹454 per share
-
-
Lot Size:
-
Minimum of 33 shares per lot
-
Investment starts from approx ₹14,982 per application
-
-
Issue Size:
-
Total issue size is ₹1,500 crore, consisting of fresh shares and offer for sale (OFS)
-
-
Listing Exchange:
-
Shares will be listed on both NSE and BSE
-
-
Use of Funds:
-
Company plans to expand manufacturing capacity, repay debt, and invest in infrastructure growth.
-
Subscription Status So Far
As of the most recent update from stock exchanges, the IPO has seen solid interest from all investor groups:
-
Retail Investors:
-
Oversubscribed more than 8.4 times
-
Strong trust from small investors due to company’s brand and past performance
-
-
Qualified Institutional Buyers (QIBs):
-
Subscribed over 19.2 times so far
-
Mutual funds, insurance firms, and pension houses showing strong support
-
-
Non-Institutional Investors (NIIs):
-
High Net-Worth Individuals (HNIs) have subscribed the portion around 16.7 times
-
-
Overall Subscription:
-
Total demand across all categories crossed 15.5 times the available shares (as of this morning)
-
Latest Grey Market Premium (GMP)
The Grey Market Premium (GMP) gives a rough idea of how the stock might perform once listed.
-
Current GMP for Anthem Biosciences: ₹95–₹100 per share
-
Expected Listing Price (based on GMP): ₹550–₹555
-
Premium Over Upper Price Band: 20%–22% potential gain on listing day
Note: GMP is unofficial and fluctuates. While it gives hints of investor sentiment, it shouldn’t be the only factor in your decision-making.
Should You Consider Applying Today?
Here are a few easy-to-understand reasons why investors are excited—and why you might consider joining them:
-
Solid Financials:
-
Strong profit margins and steady year-on-year growth.
-
-
Established Market Position:
-
A trusted name in the contract manufacturing space with international reach.
-
-
Industry Growth:
-
Biopharma and research manufacturing are booming sectors post-pandemic.
-
-
Valuation Reasonable:
-
Many analysts believe the price band offers a good entry for long-term value.
-
-
Strong Demand:
-
High subscription numbers show rising investor confidence.
-
Things to Watch Before You Apply
Even if the IPO looks promising, it's smart to consider a few key points:
-
High Competition:
-
The sector is attractive but also crowded. Long-term growth depends on how well Anthem maintains its edge.
-
-
GMP Not Guaranteed:
-
Grey Market Premium can change quickly—final listing gains may vary.
-
-
Long-Term vs Short-Term Goal:
-
Are you applying for listing gains or holding long-term? Align your strategy accordingly.
-
How to Apply for the IPO (Step-by-Step)
If you're applying through your broker or a UPI-based app like Zerodha, Upstox, or Groww:
-
Login to your trading account or app
-
Go to IPO section
-
Select ‘Anthem Biosciences Ltd’ from the list
-
Enter quantity in multiples of lot size (33 shares)
-
Choose cut-off price option (for retail investors)
-
Submit bid and confirm UPI request
-
Check application status on exchange or app dashboard
You must complete your application before 5 PM today.
Final Verdict
The Anthem Biosciences IPO has seen robust demand from every category of investor, with high GMP and promising financial fundamentals. If you’ve been watching this issue and still haven’t applied—now is your final window to make a decision.
If you're investing for the long term, the company’s future in the growing pharma and biosciences market makes it a potentially strong pick. For those seeking listing day gains, the GMP signals a positive start—but as always, proceed with care.
